Literature DB >> 26621286

Erratum to: The UBC-40 Urothelial Bladder Cancer Cell Line Index: a genomic resource for functional studies.

Julie Earl1,2, Daniel Rico3, Enrique Carrillo-de-Santa-Pau4, Benjamín Rodríguez-Santiago5,6, Marinela Méndez-Pertuz7, Herbert Auer8, Gonzalo Gómez9, H Barton Grossman10, David G Pisano11, Wolfgang A Schulz12, Luis A Pérez-Jurado13,14, Alfredo Carrato15, Dan Theodorescu16, Stephen Chanock17, Alfonso Valencia18, Francisco X Real19,20.   

Abstract

Entities:  

Year:  2015        PMID: 26621286      PMCID: PMC4681452          DOI: 10.1186/s12864-015-2227-4

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


× No keyword cloud information.
Following the publication of our recent article in BMC Genomics [1] a number of aspects were called to our attention. We have carefully reviewed the experiments reported in this manuscript, as well as additional data from our laboratories, and would like to make the following points: SW-850, included in our paper as a bladder cancer cell line, has been reported by several authors to be a pancreatic cancer cell line [2-5]. This is unlikely to be the case given that most pancreatic cancers are KRAS-mutant and both our analysis and a previous publication [5] indicate that the cells used are KRAS-wild type. However, given the controversy we recommend that these cells are not be used as bladder cancer models. The Materials and Methods section of our paper indicated that the following cell lines were obtained from ATCC: 253 J, 575A, 639 V, JON, MGH-U4, SW-800, SW-1710, VM-CUB-2. However, these cultures have never been distributed by the ATCC. Therefore, they are available from us if other investigators are interested in using them. It has been reported that UM-UC-2 is a T24 contaminant (http://www.ncbi.nlm.nih.gov/biosample/SAMN03151953 ,http://web.expasy.org/cellosaurus/CVCL_8155, http://iclac.org/wp-content/uploads/Cross-Contaminations-v7_2.pdf). We have used fingerprinting analysis to confirm this fact and the genetic identity of the cells/DNAs used in our experiments (Table 1).
Table 1

SNP fingerprint analysis of the bladder cancer cell lines suffering from an “identity crisis”

Cell LineCommentsD5S818D13S317D7S820D16S539VWATH01AMTPOXCSF1PO
VM- CUB-1 p2911108,1111,1218,199X811
VM-CUB-2 p11211,131289147X,Y8,1211,12
VM-CUB-3 p65119,128,912169.3X812
UM-UC-2 p264DNA fingerprinting data, same as T2410,1210,1210,119176X8,1110,12
T24 p8ATCC10,121210,11917,196X8,1110,12

P passage

It has been reported that VM-CUB-3 is a VM-CUB-1 contaminant (http://iclac.org/wp-content/uploads/Cross-Contaminations-v7_2.pdf, http://www.ncbi.nlm.nih.gov/biosample/3152040, http://web.expasy.org/cellosaurus/CVCL_9830). Nevertheless, our data indicate that the two cultures we used as VM-CUB-1 and VM-CUB-3 are distinct at the genomic level. Furthermore, as shown in Table 1, fingerprinting analysis clearly indicates that VM-CUB-1, VM-CUB-2, and VM-CUB-3 are different from each other. The origin of the DNA/cells in our paper was as indicated in the Material and Methods section and, therefore, investigators interested in these cells could directly address the corresponding co-authors. SNP fingerprint analysis of the bladder cancer cell lines suffering from an “identity crisis” P passage In the last few years there has been much emphasis on the need to accurately designate, identify, and characterize cancer cell lines as they are precious tools for cell biology studies [6, 7]. It is with this aim that we wish to make these comments and clarifications related to our recently published work.
  7 in total

1.  A resource for cell line authentication, annotation and quality control.

Authors:  Mamie Yu; Suresh K Selvaraj; May M Y Liang-Chu; Sahar Aghajani; Matthew Busse; Jean Yuan; Genee Lee; Franklin Peale; Christiaan Klijn; Richard Bourgon; Joshua S Kaminker; Richard M Neve
Journal:  Nature       Date:  2015-04-16       Impact factor: 49.962

2.  Reproducibility: changing the policies and culture of cell line authentication.

Authors:  Leonard P Freedman; Mark C Gibson; Stephen P Ethier; Howard R Soule; Richard M Neve; Yvonne A Reid
Journal:  Nat Methods       Date:  2015-06       Impact factor: 28.547

3.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

4.  Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis.

Authors:  C Müller; A G Bockhorn; S Klusmeier; M Kiehl; C Roeder; H Kalthoff; O M Koch
Journal:  Int J Oncol       Date:  1998-03       Impact factor: 5.650

Review 5.  One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.

Authors:  J Fogh; J M Fogh; T Orfeo
Journal:  J Natl Cancer Inst       Date:  1977-07       Impact factor: 13.506

6.  p53 and K-RAS alterations in pancreatic epithelial cell lesions.

Authors:  H Kalthoff; W Schmiegel; C Roeder; D Kasche; A Schmidt; G Lauer; H G Thiele; G Honold; K Pantel; G Riethmüller
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

7.  The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.

Authors:  Julie Earl; Daniel Rico; Enrique Carrillo-de-Santa-Pau; Benjamín Rodríguez-Santiago; Marinela Méndez-Pertuz; Herbert Auer; Gonzalo Gómez; Herbert Barton Grossman; David G Pisano; Wolfgang A Schulz; Luis A Pérez-Jurado; Alfredo Carrato; Dan Theodorescu; Stephen Chanock; Alfonso Valencia; Francisco X Real
Journal:  BMC Genomics       Date:  2015-05-22       Impact factor: 3.969

  7 in total
  1 in total

1.  Erratum to: The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies.

Authors:  Julie Earl; Daniel Rico; Enrique Carrillo-de-Santa-Pau; Benjamín Rodríguez-Santiago; Marinela Méndez-Pertuz; Herbert Auer; Gonzalo Gómez; H Barton Grossman; David G Pisano; Wolfgang A Schulz; Luis A Pérez-Jurado; Alfredo Carrato; Dan Theodorescu; Stephen Chanock; Alfonso Valencia; Francisco X Real
Journal:  BMC Genomics       Date:  2016-10-25       Impact factor: 3.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.